HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.
News|Articles|July 17, 2026
Hereditary Hemochromatosis: A Preventable Burden Hidden in Plain Sight
Author(s)Maggie L. Shaw
Fact checked by: Laura Joszt, MA
A common, underdiagnosed genetic disorder, hereditary hemochromatosis is costly when caught late and simple to treat when caught early.
Advertisement
Advertisement
One of the most common inherited genetic disorders in the US is quietly driving cirrhosis, heart failure, and diabetes as well as years of unnecessary specialist care, all largely preventable with a blood test and a timely diagnosis, according to Usha Perepu, MD, a nationally recognized classical hematology expert and director of classical hematology at the Mays Cancer Center at UT Health San Antonio.
Related to this article
Phentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.
Satralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.
A higher PNR is associated with lower odds of MASLD and advanced liver fibrosis, but further studies are needed to validate findings.
Speakers at CHEST 2026 walked through the first CHEST guideline for non-CF adult bronchiectasis, including which preventive therapy to start first.
Non-Hodgkin lymphoma mortality trends impact lower-income, less-educated communities, highlighting health disparities and needs for health equity.
SaTScan detects an acute HCV outbreak cluster in California, showing the potential of automated surveillance, though real-time testing is needed.
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Advertisement
Advertisement